US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Elicio Therapeutics

1.92

+0.10005.49%

Post-market: 1.920.00000.00%16:10 EDT

Volume:309.85K

Turnover:592.49K

Market Cap:50.46M

PE:-0.88

High:1.96

Open:1.82

Low:1.82

Close:1.82

52wk High:16.00

52wk Low:1.71

Shares:26.28M

Float Shares:19.19M

Volume Ratio:1.07

T/O Rate:1.61%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.1721

EPS(LYR):-2.5842

ROE:-774.56%

ROA:-77.88%

PB:6.36

PE(LYR):-0.74

Loading ...

Overview Company News Filings

Elicio Therapeutics - Plans to Initiate Phase 1 Study in Metastatic Pancreatic Ductal Adenocarcinoma

THOMSON REUTERS

Elicio Therapeutics Reports Multiple Complete Responses After Eli-002 7P Treatment and Subsequent Therapy With Checkpoint Inhibition in Metastatic Mkras Pancreatic Cancer

THOMSON REUTERS

SueWallSt opens probe into Elicio Therapeutics officers, directors after 72.53% stock plunge

Elicio Therapeutics Cut to Hold From Buy by Jones Trading

Elicio Therapeutics downgraded to Hold from Buy at JonesResearch

BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex

Top Midday Decliners

MT Newswires Live

Elicio shares tumble after pancreatic cancer therapy misses mid-stage study goal

Elicio selloff brings attractive entry point, says H.C. Wainwright

Elicio Unveils Phase 2 ELI-002 Results and Phase 3 Plan

Elicio Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Elicio Therapeutics Shares Fall After Missing Primary Endpoint in Pancreatic Cancer Trial

MT Newswires Live

Elicio Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $23 From $17

THOMSON REUTERS

Elicio Therapeutics Shares Fall 50% Premarket After Co Reports Mid-Stage Data for Its Experimental Pancreatic Cancer Therapy

THOMSON REUTERS

BUZZ-Elicio Therapeutics tumbles as pancreatic cancer vaccine misses main goal of trial

Elicio says Phase 2 AMPLIFY-7P trial of ELI-002 7P misses primary DFS endpoint in adjuvant pancreatic cancer

Elicio Therapeutics - Eli-2 7P Demonstrates Favorable Safety and Tolerability Profile

THOMSON REUTERS

Elicio Therapeutics Reports Results From Phase 2 Amplify-7P Study and Outlines Refined Phase 3 Development Strategy for Eli-002 7P in Adjuvant Pancreatic Cancer

THOMSON REUTERS

Elicio Therapeutics - Evaluating Strategic Financing and Partnering Opportunities

THOMSON REUTERS

Elicio Therapeutics - to Focus Phase 3 Development on R0 Resected Population With Additional Eli-2 7P Dosing

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/ELTX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","market":"US","secType":"STK","nameCN":"Elicio Therapeutics","latestPrice":1.92,"timestamp":1790884800000,"preClose":1.82,"halted":0,"volume":309854,"hourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.92,"latestTime":"16:10 EDT","volume":1411,"amount":2709.12,"timestamp":1790885404573,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.05494505494505487,"floatShares":19192300,"shares":26281900,"eps":-2.172087,"marketStatus":"Post-Mkt","change":0.1,"latestTime":"10-01 17:20:54 EDT","open":1.82,"high":1.9599,"low":1.82,"amount":592485,"amplitude":0.076868,"askPrice":1.99,"askSize":350,"bidPrice":1.93,"bidSize":394,"shortable":3,"etf":0,"ttmEps":-2.172087,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1790899200000},"marketStatusCode":4,"adr":0,"listingDate":1612501200000,"exchange":"NASDAQ","adjPreClose":1.82,"preHourTrading":{"tag":"盘前","latestPrice":1.8198,"preClose":1.82,"latestTime":"08:54 EDT","volume":20,"amount":36.398199999999996,"timestamp":1790859284677,"change":-0.0002,"changeRate":-0.00011,"amplitude":0.00011},"postHourTrading":{"tag":"盘后","latestPrice":1.92,"preClose":1.92,"latestTime":"16:10 EDT","volume":1411,"amount":2709.12,"timestamp":1790885404573,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.065744,"impliedVol":1.5877,"impliedVolPercentile":0.4462},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELTX\",,,,,undefined,":{"symbol":"ELTX","floatShares":19192300,"roa":"-77.88%","roe":"-774.56%","lyrEps":-2.584186,"volumeRatio":1.065744,"shares":26281900,"dividePrice":0,"high":1.9599,"amplitude":0.076868,"preClose":1.82,"low":1.82,"week52Low":1.705,"pbRate":"6.36","week52High":16,"institutionHeld":0,"latestPrice":1.92,"committee":0.05914,"eps":-2.172087,"divideRate":0,"volume":309854,"delay":0,"ttmEps":-2.172087,"open":1.82,"prevYearClose":7.96,"prevWeekClose":1.84,"prevMonthClose":1.82,"prevQuarterClose":1.82,"fiveDayClose":1.88,"twentyDayClose":2.55,"sixtyDayClose":3.49},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELTX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-13","symbol":"ELTX","fiscalQuarterEnding":"2026/06","expectedEps":-0.53,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786593600000,"reportTimeType":"post","actualEps":-0.43},{"market":"US","date":"2026-05-11","symbol":"ELTX","fiscalQuarterEnding":"2026/03","expectedEps":-0.49,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778472000000,"reportTimeType":"post","actualEps":-0.65},{"market":"US","date":"2026-03-12","symbol":"ELTX","fiscalQuarterEnding":"2025/12","expectedEps":-0.47,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.49},{"market":"US","date":"2025-11-13","symbol":"ELTX","fiscalQuarterEnding":"2025/09","expectedEps":-0.62,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.6},{"market":"US","date":"2025-08-07","symbol":"ELTX","fiscalQuarterEnding":"2025/06","expectedEps":-0.69,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1781841600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELTX","date":"2026-09-30","current":-0.895452,"percent":0.866071,"low":-9.235249,"twenty":-3.168832,"median":-2.174101,"eighty":-1.395448,"high":-0.963611,"avg":-2.483163,"sd":1.269732,"marketCap":48358662},"quantilePoints":[{"date":"2023-06-09","current":-9.235249,"twenty":-9.235249,"median":-9.19865,"eighty":-8.861936,"marketCap":260505032},{"date":"2023-06-16","current":-4.797096,"twenty":-9.19133,"median":-5.471097,"eighty":-5.286091,"marketCap":135315000},{"date":"2023-06-23","current":-3.669177,"twenty":-9.011993,"median":-5.35246,"eighty":-4.343178,"marketCap":103499000},{"date":"2023-06-30","current":-3.232452,"twenty":-8.711878,"median":-5.281964,"eighty":-3.931212,"marketCap":91180000},{"date":"2023-07-07","current":-3.782657,"twenty":-7.82363,"median":-4.797096,"eighty":-3.594899,"marketCap":106700000},{"date":"2023-07-14","current":-3.799851,"twenty":-5.457342,"median":-4.009616,"eighty":-3.669177,"marketCap":107185000},{"date":"2023-07-21","current":-3.868626,"twenty":-5.416077,"median":-3.868626,"eighty":-3.616907,"marketCap":109125000},{"date":"2023-07-28","current":-3.026831,"twenty":-5.342487,"median":-3.782657,"eighty":-3.314983,"marketCap":85379914},{"date":"2023-08-04","current":-2.958445,"twenty":-5.286091,"median":-3.758585,"eighty":-2.99472,"marketCap":83450898},{"date":"2023-08-11","current":-2.973312,"twenty":-5.075638,"median":-3.643386,"eighty":-2.969744,"marketCap":83870250},{"date":"2023-08-18","current":-2.842099,"twenty":-4.570137,"median":-3.57633,"eighty":-2.953093,"marketCap":83656289},{"date":"2023-08-25","current":-2.726636,"twenty":-4.18018,"median":-3.222136,"eighty":-2.868421,"marketCap":79553028},{"date":"2023-09-01","current":-2.370739,"twenty":-4.067388,"median":-3.000071,"eighty":-2.849368,"marketCap":69169264},{"date":"2023-09-07","current":-2.433882,"twenty":-3.951844,"median":-2.973312,"eighty":-2.844375,"marketCap":71011545},{"date":"2023-09-15","current":-2.413791,"twenty":-3.886508,"median":-2.973312,"eighty":-2.761879,"marketCap":70425365},{"date":"2023-09-22","current":-2.293245,"twenty":-3.841116,"median":-2.967365,"eighty":-2.647421,"marketCap":66908283},{"date":"2023-09-29","current":-2.413791,"twenty":-3.792973,"median":-2.953985,"eighty":-2.537207,"marketCap":70425365},{"date":"2023-10-04","current":-2.276024,"twenty":-3.782657,"median":-2.940605,"eighty":-2.474064,"marketCap":66405843},{"date":"2023-10-10","current":-2.098075,"twenty":-3.781281,"median":-2.875192,"eighty":-2.428715,"marketCap":61213961},{"date":"2023-10-19","current":-2.009101,"twenty":-3.779218,"median":-2.868708,"eighty":-2.413791,"marketCap":58618021},{"date":"2023-10-27","current":-1.922996,"twenty":-3.775091,"median":-2.867273,"eighty":-2.413791,"marketCap":56105820},{"date":"2023-11-03","current":-1.871334,"twenty":-3.740703,"median":-2.849368,"eighty":-2.290949,"marketCap":54598499},{"date":"2023-11-10","current":-1.690515,"twenty":-3.669177,"median":-2.844944,"eighty":-2.243878,"marketCap":49322877},{"date":"2023-11-17","current":-1.533738,"twenty":-3.658861,"median":-2.768921,"eighty":-2.084298,"marketCap":50453368},{"date":"2023-11-24","current":-1.527374,"twenty":-3.617595,"median":-2.739552,"eighty":-1.974659,"marketCap":50244018},{"date":"2023-12-01","current":-1.565558,"twenty":-3.614157,"median":-2.617571,"eighty":-1.90147,"marketCap":51500118},{"date":"2023-12-08","current":-1.48919,"twenty":-3.583895,"median":-2.583129,"eighty":-1.87076,"marketCap":48987917},{"date":"2023-12-15","current":-1.540102,"twenty":-3.452534,"median":-2.531467,"eighty":-1.708711,"marketCap":50662718},{"date":"2023-12-22","current":-1.476462,"twenty":-3.314983,"median":-2.474064,"eighty":-1.60527,"marketCap":48569217},{"date":"2023-12-29","current":-2.102685,"twenty":-3.232452,"median":-2.429577,"eighty":-1.641927,"marketCap":69169264},{"date":"2024-01-05","current":-2.03949,"twenty":-3.220072,"median":-2.413791,"eighty":-1.611379,"marketCap":67090423},{"date":"2024-01-12","current":-1.576818,"twenty":-3.100826,"median":-2.392265,"eighty":-1.585578,"marketCap":51870515},{"date":"2024-01-19","current":-1.427896,"twenty":-3.005423,"median":-2.30616,"eighty":-1.564031,"marketCap":46971633},{"date":"2024-01-26","current":-1.124213,"twenty":-2.973312,"median":-2.283466,"eighty":-1.540772,"marketCap":36981756},{"date":"2024-02-02","current":-1.314015,"twenty":-2.973312,"median":-2.260238,"eighty":-1.528392,"marketCap":43225429},{"date":"2024-02-09","current":-1.226414,"twenty":-2.973312,"median":-2.227231,"eighty":-1.508027,"marketCap":40343734},{"date":"2024-02-16","current":-1.220574,"twenty":-2.970933,"median":-2.10038,"eighty":-1.496317,"marketCap":40151621},{"date":"2024-02-23","current":-1.170933,"twenty":-2.967365,"median":-2.077039,"eighty":-1.484607,"marketCap":38518660},{"date":"2024-03-01","current":-1.185534,"twenty":-2.965581,"median":-2.037802,"eighty":-1.427936,"marketCap":38998943},{"date":"2024-03-08","current":-1.305255,"twenty":-2.958445,"median":-1.951697,"eighty":-1.350807,"marketCap":42937259},{"date":"2024-03-15","current":-1.530098,"twenty":-2.956661,"median":-1.917256,"eighty":-1.360152,"marketCap":50333611},{"date":"2024-03-22","current":-1.927222,"twenty":-2.947741,"median":-1.909363,"eighty":-1.380707,"marketCap":63397296},{"date":"2024-03-28","current":-2.178345,"twenty":-2.940605,"median":-1.925109,"eighty":-1.425549,"marketCap":71658156},{"date":"2024-04-05","current":-2.18389,"twenty":-2.875192,"median":-1.928736,"eighty":-1.427896,"marketCap":76862025},{"date":"2024-04-12","current":-2.872164,"twenty":-2.872164,"median":-2.000282,"eighty":-1.428095,"marketCap":101085828},{"date":"2024-04-19","current":-2.390082,"twenty":-2.870144,"median":-2.037802,"eighty":-1.436656,"marketCap":84118945},{"date":"2024-04-26","current":-2.64274,"twenty":-2.867273,"median":-2.070475,"eighty":-1.460017,"marketCap":93011227},{"date":"2024-05-03","current":-2.613699,"twenty":-2.860548,"median":-2.080854,"eighty":-1.476462,"marketCap":91989126},{"date":"2024-05-10","current":-2.758904,"twenty":-2.852923,"median":-2.121507,"eighty":-1.483377,"marketCap":97099633},{"date":"2024-05-17","current":-2.458726,"twenty":-2.860548,"median":-2.154849,"eighty":-1.484098,"marketCap":95873111},{"date":"2024-05-24","current":-2.3198,"twenty":-2.852923,"median":-2.20556,"eighty":-1.486644,"marketCap":90455973},{"date":"2024-05-31","current":-1.968554,"twenty":-2.850079,"median":-2.181118,"eighty":-1.488681,"marketCap":76759815},{"date":"2024-06-07","current":-2.125179,"twenty":-2.849368,"median":-2.152608,"eighty":-1.489212,"marketCap":82867106},{"date":"2024-06-14","current":-2.233016,"twenty":-2.846714,"median":-2.152608,"eighty":-1.492255,"marketCap":87071996},{"date":"2024-06-21","current":-1.741174,"twenty":-2.844944,"median":-2.140329,"eighty":-1.496317,"marketCap":67893594},{"date":"2024-06-28","current":-1.812189,"twenty":-2.844944,"median":-2.140329,"eighty":-1.498354,"marketCap":70662668},{"date":"2024-07-05","current":-0.967903,"twenty":-2.843237,"median":-2.110101,"eighty":-1.488172,"marketCap":37741454},{"date":"2024-07-12","current":-1.249432,"twenty":-2.834001,"median":-2.100781,"eighty":-1.469884,"marketCap":48719089},{"date":"2024-07-15","current":-1.260464,"twenty":-2.831302,"median":-2.098877,"eighty":-1.455345,"marketCap":49149280},{"date":"2024-08-02","current":-1.401267,"twenty":-2.828603,"median":-2.098877,"eighty":-1.436656,"marketCap":54639616},{"date":"2024-08-09","current":-1.290931,"twenty":-2.802466,"median":-2.080854,"eighty":-1.401267,"marketCap":50337284},{"date":"2024-08-16","current":-1.201045,"twenty":-2.796658,"median":-2.072003,"eighty":-1.349055,"marketCap":46438413},{"date":"2024-08-23","current":-1.241178,"twenty":-2.769689,"median":-2.062918,"eighty":-1.296495,"marketCap":47990130},{"date":"2024-08-30","current":-1.113164,"twenty":-2.768153,"median":-2.038646,"eighty":-1.281895,"marketCap":43040476},{"date":"2024-09-06","current":-1.110381,"twenty":-2.760754,"median":-2.011962,"eighty":-1.261256,"marketCap":42932874},{"date":"2024-09-13","current":-1.132616,"twenty":-2.753755,"median":-1.991463,"eighty":-1.24953,"marketCap":43792608},{"date":"2024-09-20","current":-1.430415,"twenty":-2.736707,"median":-1.971607,"eighty":-1.23844,"marketCap":55307011},{"date":"2024-09-27","current":-1.355277,"twenty":-2.727862,"median":-1.927222,"eighty":-1.247781,"marketCap":52401779},{"date":"2024-10-04","current":-1.35806,"twenty":-2.717602,"median":-1.920126,"eighty":-1.24953,"marketCap":52509380},{"date":"2024-10-11","current":-1.333014,"twenty":-2.703726,"median":-1.89225,"eighty":-1.251663,"marketCap":51540970},{"date":"2024-10-18","current":-1.327448,"twenty":-2.69392,"median":-1.871334,"eighty":-1.251663,"marketCap":51325767},{"date":"2024-10-25","current":-1.330231,"twenty":-2.68748,"median":-1.868821,"eighty":-1.256738,"marketCap":51433368},{"date":"2024-10-31","current":-1.15769,"twenty":-2.682816,"median":-1.860061,"eighty":-1.249543,"marketCap":44762095},{"date":"2024-11-08","current":-1.282921,"twenty":-2.678751,"median":-1.809791,"eighty":-1.251136,"marketCap":49604148},{"date":"2024-11-15","current":-1.251898,"twenty":-2.674104,"median":-1.720841,"eighty":-1.252073,"marketCap":58642648},{"date":"2024-11-22","current":-1.176095,"twenty":-2.654356,"median":-1.667384,"eighty":-1.249488,"marketCap":55091809},{"date":"2024-11-29","current":-1.171024,"twenty":-2.64274,"median":-1.629813,"eighty":-1.227353,"marketCap":54854273},{"date":"2024-12-06","current":-1.106606,"twenty":-2.639384,"median":-1.600178,"eighty":-1.22448,"marketCap":51836749},{"date":"2024-12-13","current":-1.148018,"twenty":-2.631897,"median":-1.571188,"eighty":-1.222594,"marketCap":53776586},{"date":"2024-12-20","current":-1.167573,"twenty":-2.62396,"median":-1.563013,"eighty":-1.217317,"marketCap":54692620},{"date":"2024-12-27","current":-1.166423,"twenty":-2.616797,"median":-1.547739,"eighty":-1.213926,"marketCap":54638735},{"date":"2025-01-03","current":-1.182527,"twenty":-2.613699,"median":-1.540102,"eighty":-1.211814,"marketCap":55393116},{"date":"2025-01-10","current":-1.304461,"twenty":-2.611376,"median":-1.530098,"eighty":-1.211814,"marketCap":61104858},{"date":"2025-01-17","current":-1.48161,"twenty":-2.609328,"median":-1.528647,"eighty":-1.213041,"marketCap":69403049},{"date":"2025-01-24","current":-1.656458,"twenty":-2.608318,"median":-1.528647,"eighty":-1.213574,"marketCap":77593471},{"date":"2025-01-31","current":-2.167199,"twenty":-2.60789,"median":-1.530098,"eighty":-1.21433,"marketCap":101518124},{"date":"2025-02-07","current":-2.162598,"twenty":-2.593884,"median":-1.54094,"eighty":-1.214734,"marketCap":101302587},{"date":"2025-02-14","current":-1.769189,"twenty":-2.583696,"median":-1.557921,"eighty":-1.214981,"marketCap":82874137},{"date":"2025-02-21","current":-1.863515,"twenty":-2.577932,"median":-1.565558,"eighty":-1.217317,"marketCap":87292655},{"date":"2025-02-28","current":-1.902626,"twenty":-2.570137,"median":-1.584118,"eighty":-1.220574,"marketCap":89124723},{"date":"2025-03-07","current":-1.833607,"twenty":-2.564329,"median":-1.603098,"eighty":-1.220574,"marketCap":85891661},{"date":"2025-03-14","current":-2.672649,"twenty":-2.570137,"median":-1.649192,"eighty":-1.221023,"marketCap":125194918},{"date":"2025-03-21","current":-2.747078,"twenty":-2.60789,"median":-1.669929,"eighty":-1.222594,"marketCap":128681358},{"date":"2025-03-28","current":-2.594838,"twenty":-2.612537,"median":-1.719708,"eighty":-1.224155,"marketCap":121550002},{"date":"2025-04-04","current":-1.679468,"twenty":-2.612537,"median":-1.718575,"eighty":-1.22448,"marketCap":87161019},{"date":"2025-04-11","current":-1.557114,"twenty":-2.610061,"median":-1.684991,"eighty":-1.225254,"marketCap":80811079},{"date":"2025-04-17","current":-1.492618,"twenty":-2.608747,"median":-1.667384,"eighty":-1.226414,"marketCap":77463875},{"date":"2025-04-25","current":-1.557114,"twenty":-2.60789,"median":-1.641927,"eighty":-1.226584,"marketCap":80811079},{"date":"2025-05-02","current":-1.541757,"twenty":-2.60528,"median":-1.62119,"eighty":-1.227308,"marketCap":80014126},{"date":"2025-05-09","current":-1.710675,"twenty":-2.59278,"median":-1.624681,"eighty":-1.230226,"marketCap":88780614},{"date":"2025-05-16","current":-1.653585,"twenty":-2.584263,"median":-1.647756,"eighty":-1.242829,"marketCap":84795847},{"date":"2025-05-23","current":-1.600745,"twenty":-2.580531,"median":-1.656458,"eighty":-1.249451,"marketCap":82086205},{"date":"2025-05-30","current":-2.337537,"twenty":-2.570137,"median":-1.661535,"eighty":-1.249526,"marketCap":119868907},{"date":"2025-06-06","current":-2.328187,"twenty":-2.570137,"median":-1.667973,"eighty":-1.249555,"marketCap":119389431},{"date":"2025-06-13","current":-2.499606,"twenty":-2.555617,"median":-1.681559,"eighty":-1.251898,"marketCap":128179818},{"date":"2025-06-20","current":-2.480906,"twenty":-2.548647,"median":-1.689176,"eighty":-1.252132,"marketCap":127220867},{"date":"2025-06-27","current":-2.462206,"twenty":-2.546034,"median":-1.702427,"eighty":-1.256738,"marketCap":126261915},{"date":"2025-07-03","current":-2.465323,"twenty":-2.537207,"median":-1.714625,"eighty":-1.258423,"marketCap":126421741},{"date":"2025-07-11","current":-2.577524,"twenty":-2.561425,"median":-1.730079,"eighty":-1.259794,"marketCap":132175448},{"date":"2025-07-18","current":-2.898546,"twenty":-2.579766,"median":-1.757979,"eighty":-1.261058,"marketCap":148637445},{"date":"2025-07-25","current":-3.057499,"twenty":-2.600059,"median":-1.764061,"eighty":-1.263206,"marketCap":156788531},{"date":"2025-08-01","current":-3.057499,"twenty":-2.611957,"median":-1.792196,"eighty":-1.270493,"marketCap":156788531},{"date":"2025-08-08","current":-2.826862,"twenty":-2.625853,"median":-1.812189,"eighty":-1.274572,"marketCap":144961465},{"date":"2025-08-15","current":-2.971121,"twenty":-2.638357,"median":-1.82441,"eighty":-1.276242,"marketCap":162258860},{"date":"2025-08-22","current":-3.41649,"twenty":-2.660123,"median":-1.836892,"eighty":-1.279025,"marketCap":186581365},{"date":"2025-08-29","current":-3.090683,"twenty":-2.678751,"median":-1.856037,"eighty":-1.280138,"marketCap":168788391},{"date":"2025-09-05","current":-3.243125,"twenty":-2.691143,"median":-1.861215,"eighty":-1.280841,"marketCap":177113544},{"date":"2025-09-12","current":-3.461326,"twenty":-2.704217,"median":-1.868463,"eighty":-1.282305,"marketCap":189029939},{"date":"2025-09-19","current":-3.426952,"twenty":-2.741354,"median":-1.870693,"eighty":-1.282921,"marketCap":187152699},{"date":"2025-09-26","current":-3.243125,"twenty":-2.769075,"median":-1.877319,"eighty":-1.282921,"marketCap":177113544},{"date":"2025-10-03","current":-3.308884,"twenty":-2.807845,"median":-1.880771,"eighty":-1.283679,"marketCap":180704787},{"date":"2025-10-10","current":-3.302906,"twenty":-2.827907,"median":-1.893424,"eighty":-1.284815,"marketCap":180378310},{"date":"2025-10-17","current":-3.004001,"twenty":-2.847185,"median":-1.902048,"eighty":-1.285226,"marketCap":164054481},{"date":"2025-10-24","current":-2.839603,"twenty":-2.847185,"median":-1.911829,"eighty":-1.285928,"marketCap":155076375},{"date":"2025-10-31","current":-2.764876,"twenty":-2.849368,"median":-1.920126,"eighty":-1.286056,"marketCap":150995418},{"date":"2025-11-07","current":-2.711073,"twenty":-2.849092,"median":-1.927222,"eighty":-1.288006,"marketCap":148057129},{"date":"2025-11-14","current":-2.723029,"twenty":-2.847185,"median":-1.960142,"eighty":-1.291742,"marketCap":148710082},{"date":"2025-11-21","current":-3.044807,"twenty":-2.852183,"median":-1.968554,"eighty":-1.293396,"marketCap":139625737},{"date":"2025-11-28","current":-3.566883,"twenty":-2.866671,"median":-1.979039,"eighty":-1.294541,"marketCap":163566570},{"date":"2025-12-05","current":-3.172468,"twenty":-2.874818,"median":-2.003244,"eighty":-1.298088,"marketCap":145479882},{"date":"2025-12-12","current":-3.189617,"twenty":-2.895724,"median":-2.026861,"eighty":-1.30462,"marketCap":146266260},{"date":"2025-12-19","current":-3.044807,"twenty":-2.909766,"median":-2.045829,"eighty":-1.306911,"marketCap":139625737},{"date":"2025-12-26","current":-3.121023,"twenty":-2.940605,"median":-2.061171,"eighty":-1.313533,"marketCap":143120749},{"date":"2026-01-02","current":-3.033375,"twenty":-2.951309,"median":-2.069254,"eighty":-1.313919,"marketCap":139101485},{"date":"2026-01-09","current":-3.140077,"twenty":-2.967365,"median":-2.073224,"eighty":-1.319745,"marketCap":143994502},{"date":"2026-01-16","current":-2.976214,"twenty":-2.971559,"median":-2.091032,"eighty":-1.321741,"marketCap":136480226},{"date":"2026-01-23","current":-3.052429,"twenty":-2.973312,"median":-2.098877,"eighty":-1.323552,"marketCap":139975238},{"date":"2026-01-30","current":-3.079104,"twenty":-2.996791,"median":-2.104138,"eighty":-1.326335,"marketCap":141198492},{"date":"2026-02-06","current":-2.899998,"twenty":-3.001047,"median":-2.123183,"eighty":-1.329118,"marketCap":132985214},{"date":"2026-02-13","current":-3.20486,"twenty":-3.016702,"median":-2.141892,"eighty":-1.330231,"marketCap":146965263},{"date":"2026-02-20","current":-3.376345,"twenty":-3.028471,"median":-2.152608,"eighty":-1.330231,"marketCap":154829040},{"date":"2026-02-27","current":-4.473847,"twenty":-3.047094,"median":-2.164899,"eighty":-1.331344,"marketCap":205157216},{"date":"2026-03-06","current":-4.504333,"twenty":-3.057499,"median":-2.178345,"eighty":-1.333556,"marketCap":206555221},{"date":"2026-03-13","current":-4.153742,"twenty":-3.067672,"median":-2.211139,"eighty":-1.339393,"marketCap":190478164},{"date":"2026-03-20","current":-5.569355,"twenty":-3.075294,"median":-2.233016,"eighty":-1.347426,"marketCap":220384966},{"date":"2026-03-27","current":-5.030086,"twenty":-3.082722,"median":-2.237299,"eighty":-1.348526,"marketCap":199045520},{"date":"2026-04-02","current":-4.955704,"twenty":-3.086726,"median":-2.253224,"eighty":-1.350299,"marketCap":196102148},{"date":"2026-04-10","current":-4.783695,"twenty":-3.093606,"median":-2.276024,"eighty":-1.355785,"marketCap":189295601},{"date":"2026-04-17","current":-5.857586,"twenty":-3.105152,"median":-2.29181,"eighty":-1.357865,"marketCap":231790532},{"date":"2026-04-24","current":-5.50892,"twenty":-3.121023,"median":-2.3198,"eighty":-1.360347,"marketCap":217993476},{"date":"2026-05-01","current":-4.937108,"twenty":-3.143126,"median":-2.325304,"eighty":-1.369992,"marketCap":195366305},{"date":"2026-05-08","current":-4.653527,"twenty":-3.147846,"median":-2.361395,"eighty":-1.372531,"marketCap":184144700},{"date":"2026-05-15","current":-4.989852,"twenty":-3.167307,"median":-2.38041,"eighty":-1.376983,"marketCap":200517206},{"date":"2026-05-22","current":-4.532067,"twenty":-3.181169,"median":-2.40143,"eighty":-1.386168,"marketCap":182121132},{"date":"2026-05-29","current":-4.857095,"twenty":-3.20486,"median":-2.406105,"eighty":-1.387284,"marketCap":195182345},{"date":"2026-06-05","current":-6.376939,"twenty":-3.220103,"median":-2.413791,"eighty":-1.391455,"marketCap":256257310},{"date":"2026-06-12","current":-6.381517,"twenty":-3.240136,"median":-2.425271,"eighty":-1.394238,"marketCap":256441271},{"date":"2026-06-18","current":-2.156165,"twenty":-3.240734,"median":-2.415455,"eighty":-1.393681,"marketCap":86645508},{"date":"2026-06-26","current":-1.779734,"twenty":-3.235354,"median":-2.413791,"eighty":-1.395448,"marketCap":71518597},{"date":"2026-07-02","current":-2.439422,"twenty":-3.233134,"median":-2.409948,"eighty":-1.396192,"marketCap":98028157},{"date":"2026-07-10","current":-1.656339,"twenty":-3.228095,"median":-2.40143,"eighty":-1.396192,"marketCap":66559974},{"date":"2026-07-17","current":-1.518706,"twenty":-3.222138,"median":-2.38041,"eighty":-1.398476,"marketCap":61029203},{"date":"2026-07-24","current":-1.838338,"twenty":-3.220103,"median":-2.361395,"eighty":-1.400681,"marketCap":73873607},{"date":"2026-07-31","current":-1.698274,"twenty":-3.217817,"median":-2.328187,"eighty":-1.401795,"marketCap":68245142},{"date":"2026-08-07","current":-1.832502,"twenty":-3.21336,"median":-2.321111,"eighty":-1.403699,"marketCap":73639088},{"date":"2026-08-14","current":-2.06017,"twenty":-3.209035,"median":-2.293245,"eighty":-1.405369,"marketCap":82787928},{"date":"2026-08-21","current":-2.135694,"twenty":-3.203336,"median":-2.279745,"eighty":-1.406482,"marketCap":80816787},{"date":"2026-08-28","current":-2.083604,"twenty":-3.196476,"median":-2.253386,"eighty":-1.408152,"marketCap":78845646},{"date":"2026-09-04","current":-1.736336,"twenty":-3.187108,"median":-2.237299,"eighty":-1.409007,"marketCap":65704705},{"date":"2026-09-11","current":-1.465468,"twenty":-3.181169,"median":-2.233016,"eighty":-1.410419,"marketCap":55454771},{"date":"2026-09-18","current":-1.295307,"twenty":-3.172087,"median":-2.217813,"eighty":-1.405926,"marketCap":49015709},{"date":"2026-09-25","current":-1.305725,"twenty":-3.17013,"median":-2.181118,"eighty":-1.400096,"marketCap":49409938},{"date":"2026-09-30","current":-1.277944,"twenty":-3.168832,"median":-2.174101,"eighty":-1.395448,"marketCap":48358662}],"updateTime":1790880721606},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELTX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644456307","title":"Elicio Therapeutics - Plans to Initiate Phase 1 Study in Metastatic Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2644456307","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644456307?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3JN5DY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ELTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644455297","title":"Elicio Therapeutics Reports Multiple Complete Responses After Eli-002 7P Treatment and Subsequent Therapy With Checkpoint Inhibition in Metastatic Mkras Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2644455297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644455297?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:00","pubTimestamp":1781697605,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nTUA3JN5DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644276007","title":"SueWallSt opens probe into Elicio Therapeutics officers, directors after 72.53% stock plunge","url":"https://stock-news.laohu8.com/highlight/detail?id=2644276007","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644276007?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:44","pubTimestamp":1781642662,"startTime":"0","endTime":"0","summary":"SueWallSt opened a securities investigation into Elicio Therapeutics tied to disclosures on its ELI-002 7P pancreatic cancer program.Shares fell 72.53% in one session following release of Phase 2 AMPLIFY-7P results that missed the primary disease-free survival endpoint.The probe focuses on whether prior statements on ELI-002 7P prospects or the AMPLIFY-7P program were materially misleading.The alert cited a June 9 Q1 2026 filing showing zero revenue and a widening net loss driven by higher R&D spending.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL4Pybgy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644769122","title":"Elicio Therapeutics Cut to Hold From Buy by Jones Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2644769122","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644769122?lang=en_us&edition=fundamental","pubTime":"2026-06-17 00:38","pubTimestamp":1781627880,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 16, 2026 12:38 ET (16:38 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELTX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643120785","title":"Elicio Therapeutics downgraded to Hold from Buy at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2643120785","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643120785?lang=en_us&edition=fundamental","pubTime":"2026-06-16 04:11","pubTimestamp":1781554298,"startTime":"0","endTime":"0","summary":"JonesResearch downgraded Elicio Therapeutics (ELTX) to Hold from Buy without a price target The company’s Phase IIb trial failed to show a signific...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-downgraded-to-hold-from-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elicio-therapeutics-downgraded-to-hold-from-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643019200","title":"BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, Paychex","url":"https://stock-news.laohu8.com/highlight/detail?id=2643019200","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643019200?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:13","pubTimestamp":1781547236,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Datadog, Terawulf, PaychexWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: htt","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL6N42N0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAND","AAL","CONI","SCCO","TRIP","DDOG","FOXA","NCLH","COIW","ABNY","COII","XOMO","OXY","PSKY","SNK","DAL","HUT","ICOI","RIOT","ABNB","RCL","UAL","XOMX","ELTX","APA","MRAL","COIN","MUU","SHAZ","XOM","CCL","PTCT","MU","TRAW","MARA","SPCX","CVX","LUV","NEM","LXEO","NMRA","CONY","PTRN","FCX","COYY","FISV","SPCU","CMTL","LCLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643241200","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2643241200","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643241200?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:01","pubTimestamp":1781546505,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics  said Monday its Phase 2 clinical study evaluating the experimental pancreatic cancer therapy ELI-002 7p failed to meet the pre-specified primary endpoint of disease-free survival.Shares sank 72% after a surge in intraday trading volume to over 7.10 million from a daily average of about 131,000.Comtech Telecommunications  agreed to sell most of its Satellite and Space Communications segment to Gilat Satellite Networks  for $157.5 million, the companies said in separate statements Monday.Shares of Comtech Telecommunications plummeted 43% as intraday trading volume climbed to more than 3.72 million, versus a daily average of about 297,000.Fox  agreed to acquire Roku  in a cash-and-stock deal that values the TV streaming platform at about $22 billion, creating a media and technology entity with one of the largest streaming businesses in the US.Fox shares dropped 16%, with intraday trading volume rising to more than 4.48 million from the stock's daily average of about 1","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4532","IE00B7SZL793.SGD","BK4020","LU1169589451.USD","LU1169590202.USD","BK4139","FOX","BK4507","ELTX","BK4007","GILT","BK4548","ROKU","IE00B19Z4B17.USD","FOXA","BK4524","CMTL","IE0031619046.USD","IE00B66KJ199.SGD","LU1861559042.SGD","BK4108","LU1861558580.USD","LU0963586101.USD","BK4588","BK4125"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643414209","title":"Elicio shares tumble after pancreatic cancer therapy misses mid-stage study goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2643414209","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643414209?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:56","pubTimestamp":1781531805,"startTime":"0","endTime":"0","summary":"Elicio shares tumble after pancreatic cancer therapy misses mid-stage study goalJune 15 (Reuters) - Elicio Therapeutics ELTX.O shares fell about 73% in early trading on Monday after the biotech firm's","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4N42N11B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643209228","title":"Elicio selloff brings attractive entry point, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2643209228","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643209228?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:50","pubTimestamp":1781531427,"startTime":"0","endTime":"0","summary":"H.C. Wainwright views the selloff today in shares of Elicio Therapeutics (ELTX) as an attractive entry point for investors. The company presented f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elicio-selloff-brings-attractive-entry-point-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elicio-selloff-brings-attractive-entry-point-says-h-c-wainwright-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643092852","title":"Elicio Unveils Phase 2 ELI-002 Results and Phase 3 Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2643092852","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643092852?lang=en_us&edition=fundamental","pubTime":"2026-06-15 21:49","pubTimestamp":1781531391,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics ( ($ELTX) ) has provided an update. On June 15, 2026, Elicio Therapeutics reported topline results from its randomized Phase 2 ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elicio-unveils-phase-2-eli-002-results-and-phase-3-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elicio-unveils-phase-2-eli-002-results-and-phase-3-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643030252","title":"Elicio Therapeutics Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2643030252","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643030252?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:28","pubTimestamp":1781526480,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 15, 2026 08:28 ET (12:28 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203469","title":"Elicio Therapeutics Shares Fall After Missing Primary Endpoint in Pancreatic Cancer Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203469","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203469?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:19","pubTimestamp":1781525983,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics  shares were down by more than 50% in Monday's premarket activity after it said its Phase 2 clinical study evaluating the experimental pancreatic cancer therapy ELI-002 7p did not meet the pre-specified primary endpoint of disease-free survival.An imbalance in patient randomization placed more individuals with a higher risk of relapse into the active treatment group, which negatively impacted the overall trial outcome, the company said.Post-hoc analyses of secondary endpoints revealed the drug provided a measurable survival benefit for a specific subset of trial participants possessing lower residual disease, Elicio Therapeutics said.The company intends to design its Phase 3 trial exclusively around this lower-risk demographic while administering additional doses, it said.Elicio anticipates current cash will sustain operations into Q4 as it seeks strategic funding options to advance the clinical program, the company added.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ELTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643720317","title":"Elicio Therapeutics, Inc. : H.c. Wainwright Raises Target Price to $23 From $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2643720317","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643720317?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:17","pubTimestamp":1781525853,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nAZN4T2CV6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643039102","title":"Elicio Therapeutics Shares Fall 50% Premarket After Co Reports Mid-Stage Data for Its Experimental Pancreatic Cancer Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2643039102","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643039102?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:13","pubTimestamp":1781525606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4N42N13C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643203525","title":"BUZZ-Elicio Therapeutics tumbles as pancreatic cancer vaccine misses main goal of trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2643203525","media":"Reuters","labels":["shareholding","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643203525?lang=en_us&edition=fundamental","pubTime":"2026-06-15 20:08","pubTimestamp":1781525283,"startTime":"0","endTime":"0","summary":"BUZZ-Elicio Therapeutics tumbles as pancreatic cancer vaccine misses main goal of trial** Shares of biotech firm Elicio Therapeutics ELTX.O fall 50% to $7.43 premarket** Company says its experimental vaccine, ELI-002 7P, being tested in pancreatic cancer patients failed to prevent the return of the disease    ** ELTX says mid-stage study tested 144 patients after surgery and standard treatment** Says subgroup with fully removed tumors saw 35% lower risk of cancer returning** Pancreatic cancer is hard to treat as it is often diagnosed late and responds poorly to existing therapies    ** Company says vaccine triggered immune response linked to better outcomes** Plans late-stage study focused on subgroup and longer treatment - ELTX** As of last close, stock up ~87% YTD  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4N42N111:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643270305","title":"Elicio says Phase 2 AMPLIFY-7P trial of ELI-002 7P misses primary DFS endpoint in adjuvant pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2643270305","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643270305?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521223,"startTime":"0","endTime":"0","summary":"Elicio Therapeutics reported Phase 2 AMPLIFY-7P results for ELI-002 7P in adjuvant mKRAS-driven pancreatic cancer; results were presented today.The study missed its main disease-free survival goal in the overall population, weighing on the near-term registrational path.Post-hoc analyses indicated a clearer benefit in patients with complete tumor removal, supporting a narrower target population for late-stage development.Immune-response findings aligned with better clinical outcomes, reinforcing the drug’s biological activity despite the primary endpoint miss.Planning shifted to a Phase 3 program focused on completely resected patients with longer dosing; execution depends on financing or partnering.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nNDLbjbZ7f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","NDAQ","ELTX","LU2210150020.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","IE00BN0W2W23.USD","BK4007","SG9999014021.USD","BK4585","LU2095319765.USD","SG9999014039.USD","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643705372","title":"Elicio Therapeutics - Eli-2 7P Demonstrates Favorable Safety and Tolerability Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2643705372","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643705372?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA7LHSYQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643703112","title":"Elicio Therapeutics Reports Results From Phase 2 Amplify-7P Study and Outlines Refined Phase 3 Development Strategy for Eli-002 7P in Adjuvant Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2643703112","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643703112?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA7LHSYQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ELTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643427058","title":"Elicio Therapeutics - Evaluating Strategic Financing and Partnering Opportunities","url":"https://stock-news.laohu8.com/highlight/detail?id=2643427058","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643427058?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA7LHSYQ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643270582","title":"Elicio Therapeutics - to Focus Phase 3 Development on R0 Resected Population With Additional Eli-2 7P Dosing","url":"https://stock-news.laohu8.com/highlight/detail?id=2643270582","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643270582?lang=en_us&edition=fundamental","pubTime":"2026-06-15 19:00","pubTimestamp":1781521201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nTUA7LHSYQ:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELTX","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":78,"code":"91000000","status":"200"}]}}